| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |